STAT3-deficient CD8+ T cells have enhanced antitumor function with increased production of IFN-γ and granzyme in the chronic inflammatory environment of tumor tissues (61–63), which was associated with upregulated expression of Glut-1 and enhanced glycolysis and downregulated expression of CPT1B and reduced FAO (63). The gene discussed is CD8A; the disease is neoplasm.